
Pharmacally
Azetukalner
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Azetukalner
Health TidingsXenon Submits Azetukalner NDA for Focal Seizures; Pauses Psychiatry Trial EnrollmentXenon Pharmaceuticals has submitted an FDA NDA for azetukalner in focal seizures following positive Phase 2b and Phase 3 data, while temporarily pausing new enrollment in its MDD…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.